Pennsylvania’s Medical Marijuana Act: What Employers Need to Know
Society’s attitude towards marijuana has changed rapidly in the last several years. As a society, we have moved from a war on drugs to having most states legalize some form of marijuana use and possession. Pennsylvania is no exception. On May 17, 2016, Pennsylvania’s Medical Marijuana Act went into effect. The Medical Marijuana Act allows patients with certain medical conditions and their caretakers to obtain certification to purchase medical marijuana. Approved diagnoses include cancer, Crohn’s disease, epilepsy, glaucoma, HIV/AIDS, multiple sclerosis, Parkinson’s disease, severe chronic or intractable pain and terminal illness. Once certified, the patient and/or the patient’s caretaker may purchase medical marijuana from a licensed dispensary. As of March, 2018, there were more than 21,000 certified medical marijuana users in Pennsylvania.
The Act says little regarding medical marijuana in the workplace. Furthermore, marijuana remains illegal under federal law. For Pennsylvania’s community banks, therefore, dealing with an employee who uses medical marijuana can feel like a “catch-22,” with many conflicting concerns and protections. For example, may a bank punish someone for use of medical marijuana outside of the workplace? Does that constitute disability discrimination? Must a bank provide a reasonable accommodation for an employee’s use of medical marijuana if it impacts their job performance?
Two provisions in the Act address employment-related concerns. First, Section 510 provides that a patient “may be prohibited by an employer” from performing any task the employer deems life-threatening or could result in a public health or safety risk while under the influence of medical marijuana.
Second, Section 2103 provides that an employer may not “discharge, threaten, refuse to hire or otherwise discriminate or retaliate against an employee … on the basis of such employee’s status as an individual who is certified to use medical marijuana.” Section 2103 also says that the Act does not “require an employer to make any accommodation of the use of medical marijuana on the property or premises of any place of employment.” Finally, Section 2103 states that “[n]othing in this act shall require an employer to commit any act that would put the employer or any person acting on its behalf in violation of Federal law.”
What does this mean for community banks? In short, banks should view any employee that is a certified user of medical marijuana as a member of a “protected class” that is protected under the Americans with Disabilities Act (“ADA”) and the Pennsylvania Human Relations Act. While a bank is not required to accommodate an employee’s use of medical marijuana in the workplace, other accommodations may be required. At a minimum, if an employee is a certified user of medical marijuana and requests an accommodation, the bank should engage in the “interactive process” with the employee to determine if a reasonable accommodation is possible.
Pennsylvania courts have not yet weighed in on the extent of employers’ obligations under the Act. In some states with medical marijuana statutes, courts have ruled that employers may strictly enforce zero-tolerance policies, even against a certified medical marijuana user. Other courts have held that employers may be required to make exceptions to workplace drug polices in order to comply with the ADA. Regardless of how Pennsylvania courts may rule, banks must recognize the new risks that the Pennsylvania Medical Marijuana Act presents for the workplace.
The information contained herein is provided for general informational purposes only and may not reflect the current law in your jurisdiction. No information contained in this blog should be construed as legal advice from Shumaker Williams P.C. or the individual author, nor is it intended to be a substitute for legal counsel on any subject matter. This blog is current as of the date of original publication.
Keith A. Clark
September 14, 2018
New Bill Proposes Changes to Maryland Tip Credit
March 13, 2023
Fair lending, Artificial Intelligence and Machine Learning
February 22, 2023